You are currently viewing the summary.
See the full text- Join / Subscribe
- Buy article
- member account Enable
- Renew subscription
- Recommend a subscription to your library
- Help for librarians
Summary
Antibiotics have been taken on the chin lately. Not only resistance to anti-infective drugs increases, but pharmaceutical companies have dropped antibiotic research programs, because the drugs are difficult and expensive to manufacture. Now, a new help is on the way. Researchers report this week that they have found a way to multiply the new members of one of the most widely used antibiotic classes. These drugs, called macrolides, were first developed in the 1950s and now represent a major defense against infections. A host of possible new drugs in this class could lead to new weapons against antibiotic-resistant infections, and maybe save millions of lives.
0 Komentar